Xcout IntelSign inSubscribe

EPITOMEE MED competitors & alternatives

EPITHealthtechCaesarea, Israel

The 12 closest competitors and alternatives to EPITOMEE MED among healthtech companies — ranked by similarity to what EPITOMEE MED actually does, not by market-cap band.

$33.7MMarket cap
44Employees
12Competitors listed

Subscribe to see EPITOMEE MED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About EPITOMEE MED

Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.

EPITOMEE MED at a glance

EPITOMEE MED is a healthtech company headquartered in Caesarea, Israel. It is publicly listed (EPIT) with a market capitalisation of $33.7M. Xcout tracks 14 named people at EPITOMEE MED, including Dan Hashimshony (Chief Executive Officer).

EPITOMEE MED leadership

  • Dan HashimshonyChief Executive Officer
  • Gal AharonowitzCOO
  • Maya GabrieliCFO
  • Shimon EckhouseCo-Founder and Chairman of the Board
  • Alon HethVP Sales and Marketing
  • Gil CohenVP Research & Development

8 more named people on record for EPITOMEE MED, with roles, board committees and tenure — see the full roster →

Recent EPITOMEE MED news

Top 12 EPITOMEE MED competitors

Ranked by semantic similarity — how close each company is to EPITOMEE MED by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

InModeINMD · Aesthetics, Medical TechnologyYokne'am, Israel
64% matchPublic

Aesthetics, Medical Technology

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.

Market cap$863.4M
Employees660
InMode competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of EPITOMEE MED and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for EPITOMEE MEDand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →